You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study

 

Online download statistics by month:

Online download statistics by month: June 2022 to September 2025

AbstractFullPdf
Jun 2022519534236
Jul 2022267272126
Aug 202230030789
Sep 202226427790
Oct 2022347352103
Nov 202223423474
Dec 202219119167
Jan 202320720870
Feb 2023240242107
Mar 2023188189106
Apr 202315715773
May 202316516679
Jun 202312912961
Jul 20239810043
Aug 2023929146
Sep 202311211358
Oct 2023838357
Nov 202313213253
Dec 2023797938
Jan 2024747651
Feb 2024767640
Mar 2024173174101
Apr 202412212264
May 2024888959
Jun 202413113269
Jul 2024899157
Aug 20246666129
Sep 2024909054
Oct 202413113167
Nov 202415616583
Dec 202415015575
Jan 202512812963
Feb 202522422460
Mar 202511111162
Apr 202513813988
May 202510110167
Jun 2025939442
Jul 2025110
Sep 2025110
Total594760232807